BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 27148806)

  • 1. Selective Sequence for the Peptide-Triggered Phase Transition of Lyotropic Liquid-Crystalline Structures.
    Liu Q; Dong YD; Boyd BJ
    Langmuir; 2016 May; 32(20):5155-61. PubMed ID: 27148806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using a selective cadmium-binding peplipid to create responsive liquid crystalline nanomaterials.
    Liu Q; Wang J; Dong YD; Boyd BJ
    J Colloid Interface Sci; 2015 Jul; 449():122-9. PubMed ID: 25554088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide-sensing actuators for modulating structure in lipid-based liquid crystalline drug delivery systems.
    Liu Q; Hu J; Whittaker MR; Davis TP; Boyd BJ
    J Colloid Interface Sci; 2017 Dec; 508():517-524. PubMed ID: 28866460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterisation of bicontinuous cubic liquid crystalline systems of phytantriol and water using cryo field emission scanning electron microscopy (cryo FESEM).
    Rizwan SB; Dong YD; Boyd BJ; Rades T; Hook S
    Micron; 2007; 38(5):478-85. PubMed ID: 17011783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lyotropic Liquid Crystalline Nanostructures as Drug Delivery Systems and Vaccine Platforms.
    Chountoulesi M; Pispas S; Tseti IK; Demetzos C
    Pharmaceuticals (Basel); 2022 Mar; 15(4):. PubMed ID: 35455426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deuterated phytantriol - A versatile compound for probing material distribution in liquid crystalline lipid phases using neutron scattering.
    Yepuri NR; Clulow AJ; Prentice RN; Gilbert EP; Hawley A; Rizwan SB; Boyd BJ; Darwish TA
    J Colloid Interface Sci; 2019 Jan; 534():399-407. PubMed ID: 30245337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oil and drug control the release rate from lyotropic liquid crystals.
    Martiel I; Baumann N; Vallooran JJ; Bergfreund J; Sagalowicz L; Mezzenga R
    J Control Release; 2015 Apr; 204():78-84. PubMed ID: 25744826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct Visualization of the Structural Transformation between the Lyotropic Liquid Crystalline Lamellar and Bicontinuous Cubic Mesophase.
    Tran N; Zhai J; Conn CE; Mulet X; Waddington LJ; Drummond CJ
    J Phys Chem Lett; 2018 Jun; 9(12):3397-3402. PubMed ID: 29809009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lyotropic Liquid-Crystalline Nanosystems as Drug Delivery Agents for 5-Fluorouracil: Structure and Cytotoxicity.
    Astolfi P; Giorgini E; Gambini V; Rossi B; Vaccari L; Vita F; Francescangeli O; Marchini C; Pisani M
    Langmuir; 2017 Oct; 33(43):12369-12378. PubMed ID: 29023126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hexaarylbiimidazoles(HABI)-functionalized lyotropic liquid crystalline systems as visible light-responsive materials.
    Jia S; Graham B; Capuano B; Tan A; Hawley A; Boyd BJ
    J Colloid Interface Sci; 2020 Nov; 579():379-390. PubMed ID: 32615481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-assembled multicompartment liquid crystalline lipid carriers for protein, peptide, and nucleic acid drug delivery.
    Angelova A; Angelov B; Mutafchieva R; Lesieur S; Couvreur P
    Acc Chem Res; 2011 Feb; 44(2):147-56. PubMed ID: 21189042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlling nanostructure and lattice parameter of the inverse bicontinuous cubic phases in functionalised phytantriol dispersions.
    Fraser SJ; Mulet X; Hawley A; Separovic F; Polyzos A
    J Colloid Interface Sci; 2013 Oct; 408():117-24. PubMed ID: 23928485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel steric stabilizers for lyotropic liquid crystalline nanoparticles: PEGylated-phytanyl copolymers.
    Chong JY; Mulet X; Keddie DJ; Waddington L; Mudie ST; Boyd BJ; Drummond CJ
    Langmuir; 2015 Mar; 31(9):2615-29. PubMed ID: 25068381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of Lipid-Based Lyotropic Liquid Crystal and Effects of Guest Molecules on Its Microstructure: a Systematic Review.
    Wang X; Zhang Y; Gui S; Huang J; Cao J; Li Z; Li Q; Chu X
    AAPS PharmSciTech; 2018 Jul; 19(5):2023-2040. PubMed ID: 29869308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phytantriol based smart nano-carriers for drug delivery applications.
    Akbar S; Anwar A; Ayish A; Elliott JM; Squires AM
    Eur J Pharm Sci; 2017 Apr; 101():31-42. PubMed ID: 28137471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cubosomes as an emerging platform for drug delivery: a review of the state of the art.
    Abourehab MAS; Ansari MJ; Singh A; Hassan A; Abdelgawad MA; Shrivastav P; Abualsoud BM; Amaral LS; Pramanik S
    J Mater Chem B; 2022 Apr; 10(15):2781-2819. PubMed ID: 35315858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disposition and association of the steric stabilizer Pluronic® F127 in lyotropic liquid crystalline nanostructured particle dispersions.
    Tilley AJ; Drummond CJ; Boyd BJ
    J Colloid Interface Sci; 2013 Feb; 392():288-296. PubMed ID: 23137909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In situ monitoring of the formation of lipidic non-lamellar liquid crystalline depot formulations in synovial fluid.
    Yaghmur A; Rappolt M; Jonassen ALU; Schmitt M; Larsen SW
    J Colloid Interface Sci; 2021 Jan; 582(Pt B):773-781. PubMed ID: 32916575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bulk and dispersed aqueous phase behavior of phytantriol: effect of vitamin E acetate and F127 polymer on liquid crystal nanostructure.
    Dong YD; Larson I; Hanley T; Boyd BJ
    Langmuir; 2006 Nov; 22(23):9512-8. PubMed ID: 17073473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impurities in commercial phytantriol significantly alter its lyotropic liquid-crystalline phase behavior.
    Dong YD; Dong AW; Larson I; Rappolt M; Amenitsch H; Hanley T; Boyd BJ
    Langmuir; 2008 Jun; 24(13):6998-7003. PubMed ID: 18522450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.